Article
The identification of a novel T cell activation state controlled by a diabetogenic gene.
Journal of immunology (Baltimore, Md. : 1950) - 1 Jan 2001
Moore J K, Scheinman R I, Bellgrau D
Abstract excerpt
The cyclin-dependent kinase inhibitor p27(kip) regulates the cell cycle at the G(1)-S phase restriction point. S phase entry and cell cycle commitment in peripheral T cells requires p27(kip) degradation, normally initiated by the receipt of costimulatory signals such as those provided by B7.1 or IL-2. We have previously reported that T cells from BioBreeding (BB)-diabetes-prone (DP) rats exhibit decreased...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
